Similar Search Results

Pharmaceutical innovation, longevity, and medical expenditure in Greece, 1995 - 2010

Lichtenberg, Frank - 2015

Longitudinal, disease-level data are used to analyze the impact of pharmaceutical innovation on longevity (mean age at … pharmaceutical innovation increased mean age at death by 0.87 years (10.4 months) - about 44% of the total increase in longevity … pharmaceutical innovation. The baseline estimate of the cost per life-year gained from pharmaceutical innovation in Greece is $17 …

Persistent link: https://www.econbiz.de/10010473542

The impact of pharmaceutical innovation on longevity and medical expenditure in Sweden, 1997 - 2010 : evidence from longitudinal, disease-level data

Lichtenberg, Frank R.; Pettersson, Billie - In: Economics of innovation and new technology 23 (2014) 3/4, pp. 239-273

Persistent link: https://www.econbiz.de/10010407486

The long-term impact of price controls in medicare part D

Moreno, Gigi; Eijndhoven, Emma van; Benner, Jennifer; … - In: Forum for health economics & policy : an evolving … 20 (2017) 2, pp. 1-56

Persistent link: https://www.econbiz.de/10011817398

The impact of the entry of biosimilars : evidence from Europe

Scott Morton, Fiona; Stern, Ariel D.; Stern, Scott - 2017

Persistent link: https://www.econbiz.de/10011708133

Health care expenditures, innovation, and demographic change

Ilgin, Yasemin - 2008

Persistent link: https://www.econbiz.de/10003729378

Spurious correlation in estimation of the health production function : a note

Akkoyunlu, Sule; Lichtenberg, Frank R.; Siliverstovs, Boriss - 2009

; Innovation ; Pharmaceuticals ; Health care expenditure ; Cointegration … contribution by Lichtenberg (2004), which relates longevity in the United States to pharmaceutical innovation and public health …

Persistent link: https://www.econbiz.de/10003900852